TP53 and cancer: The results suggested that immunity and cancer-related pathways were highly concentrated in the ICD-high subtype, including the T- and B-cell receptor signaling pathway, the p53 signaling pathway, IL2-STAT5 signaling, and interleukin 1 and 17 signaling (Figures 3C–E).